Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop
- PMID: 19193910
- PMCID: PMC5393372
- DOI: 10.1210/jc.2008-1760
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop
Abstract
Background: At the Third International Workshop on Asymptomatic Primary Hyperparathyroidism (PHPT) in May 2008, recent data on the disease were reviewed. We present the results of a literature review on issues arising from the clinical presentation and natural history of PHPT.
Methods: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was reviewed, and the questions of the International Task Force were addressed by the Consensus Panel.
Conclusions: 1) Data on the extent and nature of cardiovascular involvement in those with mild disease are too limited to provide a complete picture. 2) Patients with mild PHPT have neuropsychological complaints. Although some symptoms may improve with surgery, available data remain inconsistent on their precise nature and reversibility. 3) Surgery leads to long-term gains in spine, hip, and radius bone mineral density (BMD). Because some patients have early disease progression and others lose BMD after 8-10 yr, regular monitoring (serum calcium and three-site BMD) is essential in those followed without surgery. Patients may present with normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism). Data on the incidence and natural history of this phenotype are limited. 4) In the absence of kidney stones, data do not support the use of marked hypercalciuria (>10 mmol/d or 400 mg/d) as an indication for surgery for patients. 5) Patients with bone density T-score -2.5 or less at the lumbar spine, hip, or distal one third radius should have surgery.
Figures


References
-
- Bilezikian JP, Potts Jr JT, El-Hajj Fuleihan G, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells Jr SA 2002. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Min Res 17(Suppl 2): N2-N11, and J Clin Endocrinol Metab 87:5353–5361 - PubMed
-
- Palmer M, Adami HO, Bergstrom R, Akerstrom G, Ljunghall S 1987. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 102:1–7 - PubMed
-
- Ronni-Sivula H 1985. Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 74:13–18 - PubMed
-
- Hedback G, Tisell LE, Bengtsson BA, Hedman I, Oden A 1990. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14:829–835; discussion, 836 - PubMed
-
- Ljunghall S, Jakobsson S, Joborn C, Palmer M, Rastad J, Akerstrom G 1991. Longitudinal studies of mild primary hyperparathyroidism. J Bone Miner Res 6(Suppl 2):S111—S116; discussion, S121—S124 - PubMed